Evaluation of Viscosity of a Vaginal Moisturizer

Evaluation of Perceived Effectiveness to Evaluate Viscosity of a Vaginal Moisturizer in Menopaused Women

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03782961

Enrollment

Registered

2018-12-20

Start date

2019-01-14

Completion date

2019-01-25

Last updated

2018-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopausal Women, Vaginal Dryness

Brief summary

To evaluate the perception of viscosity of a vaginal moisturizer in postmenopausal women

Detailed description

A unicentric, blind, non-comparative clinical study to prove the perceived efficacy of the research product. It will be necessary 33 female research participants, aged between 45 and 70 years menopause with complaint of vaginal dryness. The participant will remain in the study for one day, making use of the research product in the Research Center. Participants will be divided into 2 groups so that each group observes the viscosity (flow) of the test product in a different anatomical position (lying down and standing) immediately after application of the product, after 15 and 30 minutes. Participants will respond to a subjective assessment using a standardized questionnaire to capture possible feelings of discomfort during the study. A gynecologist will be available to monitor the participants throughout the study.

Interventions

DEVICEsodium lactate and combination of polymers

sodium lactate and combination of polymers (polycarbophil, carbomer and PVM / MA copolymer)

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

FEMALE

Age

45 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

* Menopausal participants for at least 6 months; * Participants with complaints of vaginal dryness; * Skin integrity in the region of product analysis; * Agreement to comply the procedures of the trial and attend the clinic on the days and times determined for applications and / or evaluations; * Understanding, agreement and signing of the Informed Consent Term.

Exclusion criteria

* Use of anti-inflammatory / immunosuppressive / antihistamine drugs up to 3 weeks prior to selection; * Pathologies and / or active skin lesions (local and / or disseminated) in the evaluation area; * Immunosuppression by drugs or active diseases; * Decompensated endocrinopathies; * Relevant clinical history or current evidence of alcohol or other drug abuse; * known history or suspected intolerance to products of the same category; * Intense sun exposure up to 15 days before evaluation; * Gynecological treatment up to 4 weeks before evaluation; * Other conditions considered by the researcher to be reasonable for disqualification of study participation.

Design outcomes

Primary

Measure	Time frame	Description
To evaluate subjectively the perceived viscosity change	Immediately after application, 15 and 30 minutes after application	Perceived viscosity change of the research product from the point of view of the target public under normal conditions of use through a questionnaire

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026